About SHEARIT LLC
Shearit, LLC is a company focused on developing Lamiflo™, a pharmacologic treatment for cerebrovascular disease, particularly acute large vessel occlusion stroke. The company has received NIH grants and is working toward FDA approval and commercialization of its product.
Development of Lamiflo™, a pharmacologic treatment for cerebrovascular diseaseResearch in extending the ischemic penumbra in large vessel occlusion strokePre-hospital administration of stroke treatmentClinical trial planning and execution (Phase I to IV)Commercialization of medical products
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SHEARIT LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.